Dueling Fools: Johnson & Johnson Bull
8580
You know it. You use it. And its dividends are healthy.
299386
Fools share their thoughts on ethanol and energy.
91012
Shell-shocked by stocks? This one's sturdy as a rock.
205425
One Fool puts Big Goo's market cap in perspective.
266449
Allow me to introduce the yellow brick road of investing. Follow this road and you will be a happy investor. Ignore it at your peril.
70066
If, through some cruel twist of fate, disco ever comes back, you'd want to invest in companies that make puffy shirts. And if the bull market is really back, then the best place to be is in the stocks of companies that manage mutual fund companies.
54362
Deconstructing a pretty good joke, and the investment lesson held within.
129678
A stock doesn't have to be loved to outperform.
738774
An investment product worthy of a spitball.
494566
NEW YORK McCann Erickson&#39;s loss of most of its Johnson & Johnson business last week is a significant blow to parent Interpublic Group--and the erosion may not be over. Interpublic&#39;s J&J losses could also spell big gains for WPP and Omnicom.
475762
I always enjoy The Motley Fool&#39;s Fool vs. Fool debates over a stock, especially when it&#39;s Apple they&#39;re talking about.
219363
NEW YORK - In its biggest purchase ever, Johnson &amp; Johnson is dropping $24.5 billion to get into the fast-growing market for implantible devices that automatically restart stopped hearts.
568413
Here's one China-themed stock that's not doing so well.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
591756
The Motley Fool - If you haven't heard of Legg Mason (NYSE: LM - News) mutual fund manager Bill Miller, it's high time you did. He's well known in the financial world for having led his Legg Mason Value Trust (FUND: LMVTX) to S&amp;P 500-beating results for a record-setting 15 consecutive years. It's hard to argue with success like that, but that's just what Roy Weitz did recently, at his fundalarm.com website.
628840
Stocks were mixed in uneven trading yesterday, as less-than-stellar economic data pressured stocks but upbeat corporate news - including the $25.4 billion deal by Johnson &amp; Johnson to buy Guidant - gave investors reasons to buy.
14643
What's better than a high-quality stock? A high-quality stock that's got the wind at its back!